{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,7]],"date-time":"2026-07-07T06:06:17Z","timestamp":1783404377770,"version":"3.54.6"},"reference-count":33,"publisher":"Oxford University Press (OUP)","issue":"1","license":[{"start":{"date-parts":[[2022,10,13]],"date-time":"2022-10-13T00:00:00Z","timestamp":1665619200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"funder":[{"DOI":"10.13039\/100012524","name":"American Lebanese Syrian Associated Charities","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100012524","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["U24HG010135"],"award-info":[{"award-number":["U24HG010135"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2022,12,13]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:p>Thoughtful integration of interruptive clinical decision support (CDS) alerts within the electronic health record is essential to guide clinicians on the application of pharmacogenomic results at point of care. St. Jude Children\u2019s Research Hospital implemented a preemptive pharmacogenomic testing program in 2011 in a multidisciplinary effort involving extensive education to clinicians about pharmacogenomic implications. We conducted a retrospective analysis of clinicians\u2019 adherence to 4783 pharmacogenomically guided CDS alerts that triggered for 12 genes and 60 drugs. Clinicians adhered to the therapeutic recommendations provided in 4392 alerts (92%). In our population of pediatric patients with catastrophic illnesses, the most frequently presented gene\/drug CDS alerts were TPMT\/NUDT15 and thiopurines (n\u2009=\u20093850), CYP2D6 and ondansetron (n\u2009=\u2009667), CYP2D6 and oxycodone (n\u2009=\u200999), G6PD and G6PD high-risk medications (n \u2009=\u200951), and CYP2C19 and proton pump inhibitors (omeprazole and pantoprazole; n\u2009=\u200950). The high adherence rate was facilitated by our team approach to prescribing and our collaborative CDS design and delivery.<\/jats:p>","DOI":"10.1093\/jamia\/ocac187","type":"journal-article","created":{"date-parts":[[2022,10,13]],"date-time":"2022-10-13T19:07:10Z","timestamp":1665688030000},"page":"132-138","source":"Crossref","is-referenced-by-count":15,"title":["Clinician adherence to pharmacogenomics prescribing recommendations in clinical decision support alerts"],"prefix":"10.1093","volume":"30","author":[{"given":"Jenny Q","family":"Nguyen","sequence":"first","affiliation":[{"name":"Department of Pharmacy and Pharmaceutical Sciences, St. Jude Children\u2019s Research Hospital , Memphis, Tennessee, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kristine R","family":"Crews","sequence":"additional","affiliation":[{"name":"Department of Pharmacy and Pharmaceutical Sciences, St. Jude Children\u2019s Research Hospital , Memphis, Tennessee, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ben T","family":"Moore","sequence":"additional","affiliation":[{"name":"Department of Pharmacy and Pharmaceutical Sciences, St. Jude Children\u2019s Research Hospital , Memphis, Tennessee, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nancy M","family":"Kornegay","sequence":"additional","affiliation":[{"name":"Department of Pharmacy and Pharmaceutical Sciences, St. Jude Children\u2019s Research Hospital , Memphis, Tennessee, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Donald K","family":"Baker","sequence":"additional","affiliation":[{"name":"Department of Information Services, St. Jude Children\u2019s Research Hospital , Memphis, Tennessee, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Murad","family":"Hasan","sequence":"additional","affiliation":[{"name":"Department of Pharmacy and Pharmaceutical Sciences, St. Jude Children\u2019s Research Hospital , Memphis, Tennessee, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrick K","family":"Campbell","sequence":"additional","affiliation":[{"name":"Department of Information Services, St. Jude Children\u2019s Research Hospital , Memphis, Tennessee, USA"},{"name":"Department of Oncology, St. Jude Children\u2019s Research Hospital , Memphis, Tennessee, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shannon M","family":"Dean","sequence":"additional","affiliation":[{"name":"Department of Information Services, St. Jude Children\u2019s Research Hospital , Memphis, Tennessee, USA"},{"name":"Department of Pediatrics, St. Jude Children\u2019s Research Hospital , Memphis, Tennesse, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mary V","family":"Relling","sequence":"additional","affiliation":[{"name":"Department of Pharmacy and Pharmaceutical Sciences, St. Jude Children\u2019s Research Hospital , Memphis, Tennessee, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James M","family":"Hoffman","sequence":"additional","affiliation":[{"name":"Department of Pharmacy and Pharmaceutical Sciences, St. Jude Children\u2019s Research Hospital , Memphis, Tennessee, USA"},{"name":"Department of the Office of Quality and Patient Safety, St. Jude Children\u2019s Research Hospital , Memphis, Tennesse, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cyrine E","family":"Haidar","sequence":"additional","affiliation":[{"name":"Department of Pharmacy and Pharmaceutical Sciences, St. Jude Children\u2019s Research Hospital , Memphis, Tennessee, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2022,10,13]]},"reference":[{"key":"2022121408282536100_ocac187-B1","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1038\/s41746-020-0221-y","article-title":"An overview of clinical decision support systems: benefits, risks, and strategies for success","volume":"3","author":"Sutton","year":"2020","journal-title":"NPJ Digit Med"},{"key":"2022121408282536100_ocac187-B2","doi-asserted-by":"publisher","DOI":"10.1002\/cpt.2387","article-title":"Pharmacogenomic clinical decision support: a review, how-to guide, and future vision","author":"Wake","journal-title":"Clin Pharmacol Ther"},{"issue":"7573","key":"2022121408282536100_ocac187-B3","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1038\/nature15817","article-title":"Pharmacogenomics in the clinic","volume":"526","author":"Relling","year":"2015","journal-title":"Nature"},{"issue":"23","key":"2022121408282536100_ocac187-B4","doi-asserted-by":"crossref","first-page":"1967","DOI":"10.2146\/ajhp160030","article-title":"Integrating pharmacogenomics into electronic health records with clinical decision support","volume":"73","author":"Hicks","year":"2016","journal-title":"Am J Health Syst Pharm"},{"issue":"e1","key":"2022121408282536100_ocac187-B5","doi-asserted-by":"crossref","first-page":"e93","DOI":"10.1136\/amiajnl-2013-001993","article-title":"Development and use of active clinical decision support for preemptive pharmacogenomics","volume":"21","author":"Bell","year":"2014","journal-title":"J Am Med Inform Assoc"},{"issue":"6","key":"2022121408282536100_ocac187-B6","doi-asserted-by":"crossref","first-page":"e1970","DOI":"10.1542\/peds.2012-3252","article-title":"A clinical case of electronic health record drug alert fatigue: consequences for patient outcome","volume":"131","author":"Carspecken","year":"2013","journal-title":"Pediatrics"},{"issue":"2","key":"2022121408282536100_ocac187-B7","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1197\/jamia.M1809","article-title":"Overriding of drug safety alerts in computerized physician order entry","volume":"13","author":"van der Sijs","year":"2006","journal-title":"J Am Med Inform Assoc"},{"issue":"3","key":"2022121408282536100_ocac187-B8","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1055\/s-0042-1748856","article-title":"Clinical decision support stewardship: best practices and techniques to monitor and improve interruptive alerts","volume":"13","author":"Chaparro","year":"2022","journal-title":"Appl Clin Inform"},{"issue":"3","key":"2022121408282536100_ocac187-B9","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1136\/amiajnl-2011-000185","article-title":"A framework for evaluating the appropriateness of clinical decision support alerts and responses","volume":"19","author":"McCoy","year":"2012","journal-title":"J Am Med Inform Assoc"},{"issue":"2","key":"2022121408282536100_ocac187-B10","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1093\/jamia\/ocy156","article-title":"Pharmacogenomic clinical decision support design and multi-site process outcomes analysis in the eMERGE Network","volume":"26","author":"Herr","year":"2019","journal-title":"J Am Med Inform Assoc"},{"issue":"1","key":"2022121408282536100_ocac187-B11","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1002\/cpt.2079","article-title":"A tutorial for pharmacogenomics implementation through end-to-end clinical decision support based on ten years of experience from PREDICT","volume":"109","author":"Liu","year":"2021","journal-title":"Clin Pharmacol Ther"},{"issue":"2","key":"2022121408282536100_ocac187-B12","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1002\/cpt.707","article-title":"Electronic medical record-integrated pharmacogenomics and related clinical decision support concepts","volume":"102","author":"Caraballo","year":"2017","journal-title":"Clin Pharmacol Ther"},{"issue":"1","key":"2022121408282536100_ocac187-B13","doi-asserted-by":"crossref","first-page":"35","DOI":"10.2217\/pgs-2021-0110","article-title":"Building an information system to facilitate pharmacogenomics clinical translation with clinical decision support","volume":"23","author":"Qin","year":"2022","journal-title":"Pharmacogenomics"},{"issue":"1","key":"2022121408282536100_ocac187-B14","doi-asserted-by":"publisher","DOI":"10.1542\/peds.2015-3479","article-title":"Pharmacogenetics for safe codeine use in sickle cell disease","volume":"138","author":"Gammal","year":"2016","journal-title":"Pediatrics"},{"issue":"4","key":"2022121408282536100_ocac187-B15","doi-asserted-by":"crossref","first-page":"191","DOI":"10.2146\/ajhp170280","article-title":"Evaluation of prescriber responses to pharmacogenomics clinical decision support for thiopurine S-methyltransferase testing","volume":"75","author":"Ubanyionwu","year":"2018","journal-title":"Am J Health Syst Pharm"},{"key":"2022121408282536100_ocac187-B16","doi-asserted-by":"publisher","DOI":"10.1146\/annurev-genom-111621-102737","article-title":"Advancing pharmacogenomics from single-gene to preemptive testing","author":"Haidar","journal-title":"Annu Rev Genomics Hum Genet"},{"issue":"1","key":"2022121408282536100_ocac187-B17","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1002\/ajmg.c.31391","article-title":"PG4KDS: a model for the clinical implementation of pre-emptive pharmacogenetics","volume":"166C","author":"Hoffman","year":"2014","journal-title":"Am J Med Genet C Semin Med Genet"},{"issue":"5","key":"2022121408282536100_ocac187-B18","doi-asserted-by":"crossref","first-page":"942","DOI":"10.1002\/cpt.1613","article-title":"Preemptively precise: returning and updating pharmacogenetic test results to realize the benefits of preemptive testing","volume":"106","author":"Haidar","year":"2019","journal-title":"Clin Pharmacol Ther"},{"issue":"5","key":"2022121408282536100_ocac187-B19","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1038\/clpt.2012.140","article-title":"A clinician-driven automated system for integration of pharmacogenetic interpretations into an electronic medical record","volume":"92","author":"Hicks","year":"2012","journal-title":"Clin Pharmacol Ther"},{"issue":"Suppl 3","key":"2022121408282536100_ocac187-B20","doi-asserted-by":"crossref","first-page":"S36","DOI":"10.6004\/jnccn.2011.0131","article-title":"Safe and successful implementation of CPOE for chemotherapy at a children's cancer center","volume":"9","author":"Hoffman","year":"2011","journal-title":"J Natl Compr Canc Netw"},{"key":"2022121408282536100_ocac187-B21","author":"Tennessee Board of Pharmacy Rules and Regulations, Chapter 1140-03-01, Standards of Practice"},{"issue":"2","key":"2022121408282536100_ocac187-B22","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1038\/gim.2016.87","article-title":"Standardizing terms for clinical pharmacogenetic test results: consensus terms from the Clinical Pharmacogenetics Implementation Consortium (CPIC)","volume":"19","author":"Caudle","year":"2017","journal-title":"Genet Med"},{"issue":"2","key":"2022121408282536100_ocac187-B23","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1038\/clpt.2014.97","article-title":"Clinical Pharmacogenetics Implementation Consortium (CPIC) guidelines for rasburicase therapy in the context of G6PD deficiency genotype","volume":"96","author":"Relling","year":"2014","journal-title":"Clin Pharmacol Ther"},{"issue":"7","key":"2022121408282536100_ocac187-B24","doi-asserted-by":"crossref","first-page":"e15653","DOI":"10.2196\/15653","article-title":"Appropriateness of overridden alerts in computerized physician order entry: systematic review","volume":"8","author":"Poly","year":"2020","journal-title":"JMIR Med Inform"},{"issue":"3","key":"2022121408282536100_ocac187-B25","doi-asserted-by":"publisher","DOI":"10.1542\/peds.2017-4111","article-title":"Optimizing drug-drug interaction alerts using a multidimensional approach","volume":"143","author":"Daniels","year":"2019","journal-title":"Pediatrics"},{"issue":"1","key":"2022121408282536100_ocac187-B26","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1002\/ajmg.c.31390","article-title":"Clinical pharmacogenetics implementation: approaches, successes, and challenges","volume":"166C","author":"Weitzel","year":"2014","journal-title":"Am J Med Genet C Semin Med Genet"},{"issue":"10","key":"2022121408282536100_ocac187-B27","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1016\/j.amjmed.2016.04.009","article-title":"Integrating pharmacogenomics into clinical practice: promise vs reality","volume":"129","author":"St Sauver","year":"2016","journal-title":"Am J Med"},{"issue":"2","key":"2022121408282536100_ocac187-B28","doi-asserted-by":"crossref","first-page":"143","DOI":"10.2146\/ajhp100113","article-title":"Development and implementation of a pharmacist-managed clinical pharmacogenetics service","volume":"68","author":"Crews","year":"2011","journal-title":"Am J Health Syst Pharm"},{"issue":"3","key":"2022121408282536100_ocac187-B29","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1016\/j.hoc.2018.01.014","article-title":"Key components of pain management for children and adults with sickle cell disease","volume":"32","author":"Brandow","year":"2018","journal-title":"Hematol Oncol Clin North Am"},{"issue":"6","key":"2022121408282536100_ocac187-B30","doi-asserted-by":"crossref","first-page":"1300","DOI":"10.1002\/cpt.1260","article-title":"The case for pharmacogenetics-guided prescribing of codeine in children","volume":"105","author":"Gammal","year":"2019","journal-title":"Clin Pharmacol Ther"},{"key":"2022121408282536100_ocac187-B31","author":"FDA","year":"2018"},{"key":"2022121408282536100_ocac187-B32","doi-asserted-by":"crossref","first-page":"n2679","DOI":"10.1136\/bmj.n2679","article-title":"Should all babies have their genome sequenced at birth?","volume":"375","author":"Biesecker","year":"2021","journal-title":"BMJ"},{"key":"2022121408282536100_ocac187-B33","author":"Campbell","year":"2013"}],"container-title":["Journal of the American Medical Informatics Association"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/jamia\/article-pdf\/30\/1\/132\/47830134\/ocac187.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jamia\/article-pdf\/30\/1\/132\/47830134\/ocac187.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,14]],"date-time":"2022-12-14T11:51:13Z","timestamp":1671018673000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jamia\/article\/30\/1\/132\/6760689"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,10,13]]},"references-count":33,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2022,10,13]]},"published-print":{"date-parts":[[2022,12,13]]}},"URL":"https:\/\/doi.org\/10.1093\/jamia\/ocac187","relation":{},"ISSN":["1067-5027","1527-974X"],"issn-type":[{"value":"1067-5027","type":"print"},{"value":"1527-974X","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2023,1,1]]},"published":{"date-parts":[[2022,10,13]]}}}